Drugs used in childhood idiopathic or benign intracranial hypertension

Archives of Disease in Childhood: Education and Practice Edition

Volumn 93, Issue 1, 2008, Pages 19-25

  Matthews, Y Y ^a  

^a WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMIODARONE; ANALGESIC AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; GLYCEROL; GROWTH HORMONE; INDOMETACIN; ISOTRETINOIN; LEVOTHYROXINE; LITHIUM; MINOCYCLINE; NALIDIXIC ACID; NITROFURANTOIN; ORAL CONTRACEPTIVE AGENT; PENICILLIN DERIVATIVE; PHENYTOIN; PREDNISONE; RETINOL DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; THIAZIDE DIURETIC AGENT; TOPIRAMATE;

ABNORMAL SENSATION; ACNE; ADRENAL SUPPRESSION; ANOREXIA; APPETITE; CATARACT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CHILDHOOD DISEASE; CLINICAL FEATURE; CUSHING SYNDROME; DIABETES MELLITUS; DIGITAL TINGLING; DISEASE DURATION; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; DYSPEPSIA; ELECTROLYTE DISTURBANCE; EUPHORIA; FENESTRATION; GASTROINTESTINAL SYMPTOM; GLAUCOMA; GROWTH INHIBITION; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MALAISE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; METALLIC TASTE; MORBIDITY; MULTIPLE CYCLE TREATMENT; MYOPATHY; NEPHROLITHIASIS; NEUROIMAGING; OBESITY; OSTEOPOROSIS; PATIENT MONITORING; PEPTIC ULCER; PERIORAL TINGLING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; RECURRENCE RISK; REVIEW; SHUNTING; SIDE EFFECT; SKIN ATROPHY; SKIN BRUISING; STRIA; SURGICAL TECHNIQUE; TASTE DISORDER; TELANGIECTASIA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION; WOUND HEALING IMPAIRMENT;

ACETAZOLAMIDE; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CARBONIC ANHYDRASE INHIBITORS; CEREBROSPINAL FLUID SHUNTS; CHILD; FUROSEMIDE; HUMANS; PSEUDOTUMOR CEREBRI;

EID: 38849113319     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2006.107326     Document Type: Review

References (86)

1. Kesler A, Hadayer A, Goldhammer Y, et al. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-9.
2. Lim M, Kurian M, Penn A, et al. Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child 2005;90:206-10.
3. Salman MS, Kirkham FJ, MacGregor DL. Idiopathic "benign" intracranial hypertension: case series and review. J Child Neurol 2001;16:465-70.
4. Youroukos S, Psychou F, Fryssiras S, et al. Idiopathic intracranial hypertension in children. J Child Neurol 2000;15:453-7.
5. Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127:178-82.
6. Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J Aapos 1998;2:33-8.
7. Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 1994;9:144-9.
8. Lessell S, Rosman NP. Permanent visual impairment in childhood pseudotumor cerebri. Arch Neurol 1986;43:801-4.
9. Couch R, Camfield PR, Tibbles JA. The changing picture of pseudotumor cerebri in children. Can J Neurol Sci 1985;12:48-50.
10. Baker RS, Carter D, Hendrick EB, et al. Visual loss in pseudotumor cerebri of childhood. A follow-up study. Arch Ophthalmol 1985;103:1681-6.
11. Quincke H. [Über Meningitis serosa und verwandte Zustände]. Deutsche Zeitschrift fur Nervenheilkunde 1897;9:149-68.
12. Nonne M. Uber Falle von Symptomenkomplex "Tumor cerebri" mit Ausgang in Heilung (Pseudotumor cerebri). Dtsch Z Nervenheilkunde 1904;27:169-216.
13. Foley J. Benign forms of intracranial hypertension; toxic and otitic hydrocephalus. Brain 1955;78:1-41.
14. Buchheit WA, Burton C, Haag B, et al. Papilledema and idiopathic intracranial hypertension. N Engl J Med 1969;280:938- 42.
15. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992;37:155-66.
16. Baker RS, Buncic JR. Vertical ocular motility disturbance in pseudotumor cerebri. J Clin Neuroophthalmol 1985;5:41-4.
17. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-74.
18. Giuseffi V, Wall M, Siegel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991;41:239-44.
19. Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye 1998;12:111- 18.
20. Radhakrishnan K, Ahlskog JE, Garrity JA, et al. Idiopathic intracranial hypertension. Mayo Clin Proc 1994;69:169-80.
21. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Ach Neurol 1988;45:875-7.
22. Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997;124:253-5.
23. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neuroi Sci 1997;24:219-21.
24. Craig JJ, Mulholland DA, Gibson JM. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulster Med J 2001;70:31-5.
25. Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999;52:870-2.
26. Wraige E, Chandler C, Pohl KR. Idiopathic intracranial hypertension: is papilledema inevitable? Arch Dis Child 2002;87:223-4.
27. Soler D, Cox T, Bullock P, et al. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998;78:89-94.
28. Amacher AL, Spence JD. Spectrum of benign intracranial hypertension in children and adolescents. Childs Nerv Syst 1985;1:81-6.
29. Distelmaier F, Sengler U, Messing-Juenger M, et al. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev 2006;28:190-5.
30. Weig SG. Asymptomatic idiopathic intracranial hypertension in young children. J Child Neurol 2002;17:239-41.
31. Weisberg LA, Chutorian AM. Pseudotumor cerebri of childhood. Am J Dis Child 1977;131:1243-8.
32. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5.
33. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974;133:802-7.
34. Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094-8.
35. Wall M. Idiopathic intracranial hypertension: mechanisms of visual loss and disease management. Semin Neurol 2000;20:89-95.
36. Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105:2313-17.
37. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155-80.
38. Kesler A, Goldhammer Y, Hadayer A, et al. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand 2004;110:408-11.
39. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998;126:116-21.
40. Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry 2004;75:813- 21.
41. Baker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol 1989;5:5-11.
42. Weisberg LA. Benign intracranial hypertension. Medicine 1975;54:197-207.
43. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002;17:745-8.
44. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58:1551-3.
45. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990;10:331-5.
46. Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46:1226-30.
47. Wang SJ, Silberstein SD, Patterson S, et al. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998;51:245-9.
48. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989;46:1049-51.
49. Gucer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg 1978;49:255-63.
50. Rubin RC, Henderson ES, Ommaya AK, et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 1966;25:430-6.
51. Pollay M, Fullenwider C, Roberts PA, et al. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983;59:945-50.
52. Vogh BP, Langham MR Jr. The effect of furosemide and bumetanide on cerebrospinal fluid formation. Brain Res 1981;221:171-83.
53. McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974;189:194-201.
54. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol 1994;9:130-4.
55. Neville BG, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ 1970;3:554-6.
56. Paterson R, Depasquale N, Mann S. Pseudotumor cerebri. Medicine 1961;40:85-99.
57. Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 2004;44:436-7.
58. Alore PL, Jay WM, Macken MP. Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective. Semin Ophthalmol 2006;21:15-17.
59. Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalmic Surg Lasers 1998;29:514-17.
60. Johnston I, Besser M, Morgan MK. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988;69:195-202.
61. Bynke G, Zemack G, Bynke H, et al. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 2004;63:1314-16.
62. McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004;101:627-32.
63. Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980;55:541-6.
64. Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005;3:CD003434.
65. Wall M. Idiopathic intracranial hypertension. Neurol Clin 1991;9:73-95.
66. Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990;47:315-20.
67. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983;33:1386-8.
68. Welch K. The intracranial pressure in infants. J Neurosurg 1980;52:693-9.
69. Eidlitz-Markus T, Stiebel-Kalish H, Rubin Y, et al. CSF pressure measurement during anesthesia: an unreliable technique. Paediatr Anaesth 2005;15:1078-82.
70. Corbett JJ. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983;10:221-9.
71. Donaldson JO. Pathogenesis of pseudotumor cerebri syndromes. Neurology 1981;31:877-80.
72. Walker RW. Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? J Neurol Neurosurg Psychiatry 2001;71:1-5.
73. Gjerris F, Soelberg Sorensen P, Vorstrup S, et al. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 1985;17:158-62.
74. Johnston I. Reduced C.S.F. absorption syndrome. Reappraisal of benign intracranial hypertension and related conditions. Lancet 1973;2:418-21.
75. Sklar FH, Beyer CW Jr, Ramanathan M, et al. Cerebrospinal fluid dynamics in patients with pseudotumor cerebri. Neurosurgery 1979;5:208-16.
76. Janny P, Chazal J, Colnet G, et al. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981;15:168-74.
77. Orefice G, Celentano L, Scaglione M, et al. Radioisotopic cisternography in benign intracranial hypertension of young obese women. A seven-case study and pathogenetic suggestions. Acta Neurol 1992;14:39-50.
78. Guess HA, Charlton JD, Johnson RN, et al. A nonlinear least-squares method for determining cerebrospinal fluid formation and absorption kinetics in pseudotumor cerebri. Comput Biomed Res 1985;18:184-92.
79. Bateman GA. Vascular hydraulics associated with idiopathic and secondary intracranial hypertension. AJNR Am J Neuroradiol 2002;23:1180-6.
80. Raichle ME, Grubb RL Jr, Phelps ME, et al. Cerebral hemodynamics and metabolism in pseudotumor cerebri. Ann Neurol 1978;4:104-11.
81. Bates GW, Whitworth NS, Parker JL, et al. Elevated cerebrospinal fluid prolactin concentration in women with pseudotumor cerebri. South Med J 1982;75:807-8.
82. Reid AC, Matheson MS, Teasdale G. Volume of the ventricles in benign intracranial hypertension. Lancet 1980;2:7-8.
83. Moser FG, Hilal SK, Abrams G, et al. MR imaging of pseudotumor cerebri. AJR Am J Roentgenol 1988;150:903-9.
84. Sorensen PS, Thomsen C, Gjerris F, et al. Brain water accumulation in pseudotumour cerebri demonstrated by MR-imaging of brain water self-diffusion. Acta Neurochir 1990;51(Suppl):363-5.
85. Bastin ME, Sinha S, Farrall AJ, et al. Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2003;74:1693-6.
86. Wall M, Dollar JD, Sadun AA, et al. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol 1995;52:141-5.